Authors


Aaron Stewart

Latest:

Advancing Spray-Dried Dispersion Formulation Development

In-vitro and in-silico tools can help predict in-vivo outcomes for low-solubility drugs formulated as spray-dried dispersions.


Rona LeBlanc-Rivera, PhD

Latest:

Drug Shortages and Complying with FDA’s 21 CFR 211.110 Guidance

Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Rona LeBlanc-Rivera, PhD, principal consultant, Regulatory Affairs at Regulatory Compliance Associates, answer some questions about FDA’s January 2025 21 CFR 211.110 guidance document.


Alessandro Regola

Latest:

Pharmaceutical Knowledge Management: Experiences in Drug Development and Manufacturing

Knowledge management has gained increasing importance in the pharmaceutical industry over the past 10–15 years


Courtney O’Dell

Latest:

A Novel Cell Lysis Method to Improve the Viral Vector Manufacturing Process

Researchers demonstrated a new cell lysis method using a novel solution to improve viral vector production.


Stefano Simonato

Latest:

Implementing Data Integrity Compliance in a GLP Test Facility

Consider how to apply ALCOA+ to a building management system in non-clinical laboratories.


Robert O. Williams III

Latest:

Improved Formulations to Enable Stable Delivery of Biologics

How dry powder techniques can overcome limitations in biologics development and delivery to broaden routes of administration and global accessibility.


Stephan K. Roenninger

Latest:

Reliance-Based Waivers Become the Predominant Trend in In-Country Testing of Pharmaceutical Products

This study reviews changes in in-country testing (registration testing, import testing) requirements and analyzes current trends. In the context of international harmonization of good practices and standards as well as the improved information exchange between national regulatory authorities, in-country testing is considered outdated and redundant in many cases.



Sara Sefton

Latest:

Integrated Approach Facilitates Inhalation Drug Development

The choice of delivery platform for inhaled drug products is contingent on API-related factors, as well as the development stage of the product.


Stephanie Sproule

Latest:

Ongoing Analytical Procedure Performance Verification—Stage 3 of USP<1220>

Analytical procedure performance can be continually verified by risk-based monitoring of performance related data.


Bernhard Eitzinger

Latest:

Printable Medicines: A Microdosing Device For Producing Personalized Medicines

The authors describe a new method for the production of personalised medicines utilising ultra-precise microdrop printing technology.


Rosa Terribile

Latest:

Enhancing Process Validation for Sterile Liquid and Freeze-Dried Forms: Part 1

AFI representatives of the process validation working group explore and define key elements for an enhanced approach to process validation for sterile liquid and freeze-dried forms.


Christian Metz

Latest:

A Harmonized Approach to Performing a Risk-Based Audit Trail Review

The IQ Working Group has defined a pragmatic risk-based approach to audit trail review, where it is only required for high impact GxP data.


Patricia Santos-Serrão

Latest:

How to Meet Regulatory Challenges in the New Year

With 2007 projects wrapped up, or so we hope, forward-looking companies need to take their next step.



DrugDigest

Latest:

Unpacking the Science Behind Data Integrity

Webinar Date/Time: Thursday February 24, 2023 at 11am EST | 10am CST | 8am PST


Graham Ruecroft

Latest:

Power Ultrasound and the Production of Mesoscopic Particles and Aqueous Dispersions

The authors discuss advanced sonocrystallization particle-engineering techniques for manufacturing mesoscopic particles.


Julian Upton

Latest:

Servier: patience and passion

You don't have to spend any time in the company of its chairman to see that there is no other Big Pharma company like Servier.


Nancy M. Clipse

Latest:

Formulation effects on the thermomechanical properties and permeability of free films and coating films

Understanding a formulation's variable effects on its properties, especially film permeability, is key to designing a robust formulation and reducing variation of a finished product.


Ian Toledo de Zayas

Latest:

Packing-Line Improvement Based on a Fault-Tree Analysis Approach

This article focuses on upgrading and improving a packing process to comply with current good manufacturing practices. The authors sought to maintain proper quality assurance for finished products.


Jake Sorofman

Latest:

Jake Sorofman Q&A

Q: You have many years of experience in marketing and business development. What are the most significant changes you have observed in this time?


Hartwig Steckel

Latest:

The extrusion and spheronization of chitosan

Chitosan is of pharmaceutical interest because of its positive attributes with respect to toxicity, biocompatibility and bioavailability.


Kathleen Martin

Latest:

The new biopharmaceutical blueprint

As a skipping stone creates ripples in a lake, SOA can help create benefits that quickly ripple through many other areas of the organization and partners.


John C. Gebler

Latest:

Improved Mass Determination of Poly(ethylene glycols) by Electrospray Ion-Mobility Time-of-Flight Mass Spectrometry Coupled with Ion–Molecule Reactions

The authors developed a method to accurately measure the average molecular weight of large poly(ethylene glycols) (PEGs) using ion-mobility time-of-flight mass spectrometry coupled with gas-phase ion–molecule reactions.


Kate Kuhrt

Latest:

The BRIC Countries: Opportunities for Regulated Market Players

The author outlines the opportunities and challenges for manufacturers aiming to enter the BRIC-country markets.


Galina Holloway

Latest:

A stability-indicating HPLC procedure for determination of diltiazem hydrochloride in extemporaneously compounded oral liquids

The stability of drugs in solid forms such as powders, tablets and capsules is usually determined very thoroughly by the drug's manufacturer. Based on stability study data, the shelf-life of a drug substance or a drug product is assigned. In addition to dispensing solid dosage forms to patients, pharmacists are frequently asked to compound oral liquid preparations for which the shelf-life or beyond-use date are assigned based on the pharmacist's best judgment - often without the benefit of stability data.


Jens Meyer

Latest:

Improving the Integrity Test Assurance of Multiround Housings Assessments

The authors describe a novel approach for the integrity testing of large sterile filter systems such as multiround housings and describe a multipoint diffusion test capable of detecting minor failures.


Takashi Hayashi

Latest:

Creating PVA copolymer capsules

When drugs are encapsulated, electrification (the electrostatic charge of the capsule) may sometimes cause problems, such as capsule adhesion during transportation or dispersion of the capsule content in the filling process.


Ray J. Newton, Jr

Latest:

Formulation effects on the thermomechanical properties and permeability of free films and coating films

Understanding a formulation's variable effects on its properties, especially film permeability, is key to designing a robust formulation and reducing variation of a finished product.


Andreas Gryczke

Latest:

Solid Dispersions by Hot-Melt Extrusion

The advantages and disadvantages of hot-melt extrusion in solid dispersion formulations.